

| 货号 | PTX18882 |
|---|---|
| 品牌 | ProteoGenix |
| 描述 |
Anti-Avelumab Polyclonal Antibody (PTX18882) is a rabbit polyclonal antibody detecting Rabbit polyclonal to Bavencio. in ELISA.
Highlights
|
| 应用 | ELISA |
| 宿主 | Rabbit |
| 同种型 | IgG |
| 克隆类型 | Polyclonal |
| 免疫原 | Avelumab |
| 靶标 | Rabbit polyclonal to Bavencio. |
| 特异性 | The product is specific for Avelumab. This antibody serves as an excellent positive control for Avelumab immunogenicity (ADA) assays. |
| 纯化方式 | Purified by antigen affinity column. |
| Accession号 | CAS: 1537032-82-8 |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| 稳定性和存储 | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
| 背景 | Avelumab with trade name Bavencio, is an FDA-approved drug to treat Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma. Avelumab is a whole monoclonal antibody of isotype IgG1 that binds to the programmed death-ligand 1 (PD-L1) and therefore inhibits binding to its receptor programmed cell death 1 (PD-1). PD-L1 can be highly expressed on certain tumors, which is thought to lead to reduced activation of immune cells (cytotoxic T-cells in particular) that might otherwise recognize and attack the cancer. Inhibition of PD-L1 by Avelumab can remove this inhibitor effect and thereby engender an anti-tumor response. It is one of several ways to block inhibitory signals related to T-cell activation, a more general strategy known as |
| Note | Antibodysystem can customize this product per customer's request including product size, buffer components, etc. For research use only. |

24小时产品查询

扫一扫关注我们

专属渠道经理